Canada Life
PCVX icon

Canada Life’s Vaxcyte PCVX Stock Holding History

Canada Life’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$838K Buy
14,463
+1,060
+8% +$57.6K ﹤0.01% 1411
2026
Q1 		$782K Hold
13,403
– – ﹤0.01% 1416
2025
Q4 		$619K Buy
13,403
+2,039
+18% +$91.2K ﹤0.01% 1471
2025
Q3 		$394K Hold
11,364
– – ﹤0.01% 1635
2025
Q2 		$370K Sell
11,364
-17,015
-60% -$558K ﹤0.01% 1650
2025
Q1 		$1.07M Hold
28,379
– – ﹤0.01% 1410
2024
Q4 		$2.32M Buy
28,379
+5,423
+24% +$538K ﹤0.01% 1200
2024
Q3 		$2.63M Hold
22,956
– – ﹤0.01% 1181
2024
Q2 		$1.74M Buy
22,956
+4,892
+27% +$333K ﹤0.01% 1343
2024
Q1 		$1.23M Buy
18,064
+11,208
+163% +$776K ﹤0.01% 1447
2023
Q4 		$428K Sell
6,856
-6,110
-47% -$317K ﹤0.01% 1731
2023
Q3 		$660K Buy
12,966
+3,596
+38% +$177K ﹤0.01% 1611
2023
Q2 		$471K Buy
9,370
+6,712
+253% +$318K ﹤0.01% 1703
2023
Q1 		$100K Hold
2,658
– – ﹤0.01% 1981
2022
Q4 		$128K Buy
2,658
+848
+47% +$33.3K ﹤0.01% 1942
2022
Q3 		$43K Hold
1,810
– – ﹤0.01% 2125
2022
Q2 		$39K Buy
1,810
+741
+69% +$17.1K ﹤0.01% 2106
2022
Q1 		$27K Hold
1,069
– – ﹤0.01% 2299
2021
Q4 		$25K Hold
1,069
– – ﹤0.01% 2334
2021
Q3 		$27K Hold
1,069
– – ﹤0.01% 2380
2021
Q2 		$24K Hold
1,069
– – ﹤0.01% 2447
2021
Q1 		$21K Hold
1,069
– – ﹤0.01% 2498
2020
Q4 		$28K Buy
+1,069
New +$39.7K ﹤0.01% 2477

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Canada Life's PCVX Position: Q2 2026 in Review

Canada Life increased its Vaxcyte (PCVX) stake by 7.9% in Q2 2026, buying an estimated $57.6K and bringing the position to 14,463 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #1411.

Canada Life first reported a position in PCVX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.63M in Q3 2024. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Canada Life held 14,463 shares of Vaxcyte worth $838K as of Q2 2026.
  • Canada Life bought 1,060 Vaxcyte shares in Q2 2026, an estimated $57.6K.
  • Vaxcyte made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1411 holding.
  • Canada Life first reported a position in Vaxcyte in Q4 2020 and has held it in 23 quarters since.
  • Canada Life's Vaxcyte position peaked at $2.63M in Q3 2024.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.